Patents by Inventor Lubomir Sebo

Lubomir Sebo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR USE IN ANALYTICAL REACTIONS
    Publication number: 20090208961
    Abstract: Compositions, methods, substrates and systems for use in analysis of single molecule reactions and particularly single molecule nucleic acid sequence analysis. Compositions that include non-reactive, distinguishable or undetectable competitive substrates for the reaction system of interest are provided, as well as their use in systems and substrates for such applications, such compounds typically preferably polyphosphate chains or analogous structures.
    Type: Application
    Filed: February 12, 2009
    Publication date: August 20, 2009
    Applicant: Pacific Biosciences of California, Inc.
    Inventors: Keith Bjornson, Arek Bibillo, Lubomir Sebo
  • Modulators of calcitonin and amylin receptor activity
    Patent number: 7396936
    Abstract: In various aspects, the present invention relates to non-peptidic compounds, which modulate calcitonin and amylin receptor activity; to processes for the preparation of some such compounds; and to pharmaceutical compositions including such compounds. Compounds of the invention are useful as calcitonin and/or amylin agonists and in the treatment of bone diseases and metabolic diseases.
    Type: Grant
    Filed: November 9, 2005
    Date of Patent: July 8, 2008
    Assignee: Kemia, Inc.
    Inventors: Kent Pryor, Jan Urban, Lubomir Sebo, Stephen Miller, Nancy Delaet
  • Modulators of calcitonin and amylin activity
    Publication number: 20070088163
    Abstract: In various aspects, the present invention relates to novel compounds, which modulate calcitonin and amylin receptor activity; to processes for the preparation of such compounds; and to pharmaceutical compositions including such compounds. Compounds of the invention are useful as calcitonin and/or amylin agonists and in the treatment of bone disease such as osteoporosis, Paget's disease, hypercalcemia, and in the treatment of metabolic diseases, such as insulin-requiring states.
    Type: Application
    Filed: September 10, 2004
    Publication date: April 19, 2007
    Inventors: Kent Pryor, Eddine Saiah, Jeffrey Kahl, Nancy Delaet, Edward Roberts, Jan Urban, Lubomir Sebo, Christopher Lum, Hiroshi Nakanishi